MAP3K3 and cerebral cavernous malformation: Supportively, ponatinib, a small-molecule compound inhibits MEKK3 activity to increase expression of the downstream Klf gene, suppresses CCM in neonatal Ccm1 deficient mouse models (Choi et al., 2018).